J. Sauter

发表

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

J. Szustakowski, P. Stephens, C. Rudin, 2018, Cancer discovery.

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

Arun Ahuja, C. Rudin, J. Wolchok, 2018, Cancer cell.

Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.

R. Scharpf, M. Brock, V. Velculescu, 2018, Cancer research.

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

V. Velculescu, J. Taube, J. Wolchok, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Regional and clonal T cell dynamics at single cell resolution in immune checkpoint blockade

Daniel K. Wells, Ansuman T. Satpathy, C. Rudin, 2021, bioRxiv.

Assessment of The Bethesda System for Reporting Thyroid Cytopathology.

M. Henry, M. Rivera, D. Dean, 2019, American journal of clinical pathology.

New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi‐Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center

N. Le Stang, N. Girard, A. Nicholson, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach.

S. Armato, P. Courtiol, N. Girard, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel

A. Nicholson, F. Galateau-Sallé, L. Chirieac, 2019, Modern Pathology.

The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.

F. Galateau-Sallé, L. Chirieac, A. Marchevsky, 2017, Human pathology.

Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

Ahmet Zehir, Ronglai Shen, Barry S Taylor, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

S. Digumarthy, J. Roth, M. Mino‐Kenudson, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcomes to first-line pembrolizumab in patients with non-small cell lung cancer and very high PD-L1 expression.

S. Digumarthy, J. Heymach, M. Hellmann, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

#EBUSTwitter: Novel Use of Social Media for Conception, Coordination and Completion of an International, Multi-Center Pathology Study

R. Wu, Surinder Kumar, S. Mukhopadhyay, 2018, Journal of the American Society of Cytopathology.

Young investigator challenge: Validation and optimization of immunohistochemistry protocols for use on cellient cell block specimens

M. Henry, J. Sauter, M. Law, 2016, Cancer cytopathology.

Results from the 2019 American Society of Cytopathology survey on rapid on-site evaluation-Part 1: objective practice patterns.

P. Illei, J. Reynolds, J. Sauter, 2019, Journal of the American Society of Cytopathology.

Validation of a digital pathology system including remote review during the COVID-19 pandemic

Bin Xu, Peter J. Schüffler, Sahussapont Joseph Sirintrapun, 2020, Modern Pathology.

Description and Classification of Thyroid Cytology

M. Henry, M. Rivera, J. Sauter, 2018 .

Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital

A. Ambaye, J. Sauter, S. Mount, 2015, Diagnostic cytopathology.

Expanding the spectrum of pulmonary histopathological manifestations of anti‐synthetase syndrome: anti‐EJ‐associated acute fibrinous and organizing pneumonia

J. Sauter, K. Butnor, 2014, Histopathology.

In Reply.

A. Nicholson, F. Galateau-Sallé, J. Sauter, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

DynamicsofTumorand ImmuneResponsesduring Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

R. Scharpf, M. Brock, V. Velculescu, 2019 .

Insights into pathogenesis of fatal COVID‐19 pneumonia from histopathology with immunohistochemical and viral RNA studies

W. Travis, S. Pittaluga, S. Morjaria, 2020, Histopathology.

Small Cell Lung Carcinoma Subtypes Defined by ASCL1, NEUROD1, POU2F3 and YAP1: Comprehensive Immunohistochemical and Histopathologic Characterization.

C. Rudin, W. Travis, N. Rekhtman, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical and Cost Implications of Universal Versus Locally Advanced-Stage and Advanced-Stage-Only Molecular Testing for Epidermal Growth Factor Receptor Mutations and Anaplastic Lymphoma Kinase Rearrangements in Non-Small Cell Lung Carcinoma: A Tertiary Academic Institution Experience.

J. Sauter, K. Butnor, 2016, Archives of pathology & laboratory medicine.

Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues

W. Travis, N. Rekhtman, A. Jungbluth, 2020, Applied immunohistochemistry & molecular morphology : AIMM.

Brief Report: Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.

M. Ladanyi, M. Zauderer, V. Rusch, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior

A. Roden, R. Graham, J. Sauter, 2017, Modern Pathology.

Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer

Jianjiong Gao, R. Vanguri, M. Ginsberg, 2022, Nature Cancer.

SCLC Subtypes De ﬁ ned by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

C. Rudin, W. Travis, N. Rekhtman, 2020 .

Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library

M. Ladanyi, M. Zauderer, C. Rudin, 2022, Genome Medicine.

Immune check‐point inhibitor‐related pneumonitis: acute lung injury with rapid progression and organising pneumonia with less severe clinical disease

W. Travis, N. Rekhtman, M. Feinstein, 2022, Histopathology.

The 2021 WHO Classi ﬁ cation of Tumors of the Pleura: Advances Since the 2015 Classi ﬁ cation

A. Nicholson, F. Galateau-Sallé, W. Travis, 2022 .

A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab.

David R. Jones, M. Zauderer, C. Rudin, 2021, Cancer discovery.

Brief Report: Molecular characterization of peritoneal mesotheliomas.

M. Ladanyi, M. Zauderer, M. Kris, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer

B. Taylor, M. Ladanyi, C. Rudin, 2020, Clinical Cancer Research.

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas

David R. Jones, M. Ladanyi, C. Rudin, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Bronchiolar Adenoma: Expansion of the Concept of Ciliated Muconodular Papillary Tumors With Proposal for Revised Terminology Based on Morphologic, Immunophenotypic, and Genomic Analysis of 25 Cases

L. Borsu, M. Ladanyi, W. Travis, 2018, The American journal of surgical pathology.

Displaced Cartilage Within Lymph Node Parenchyma Is a Novel Biopsy Site Change in Resected Mediastinal Lymph Nodes Following EBUS-TBNA

R. Wu, S. Mukhopadhyay, S. Roy-Chowdhuri, 2019, The American journal of surgical pathology.

Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma.

M. Ladanyi, M. Zauderer, V. Rusch, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas.

M. Ladanyi, C. Rudin, W. Travis, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

The 2021 World Health Organization Classification of Tumors of the Pleura: Advances since the 2015 Classification.

A. Nicholson, F. Galateau-Sallé, W. Travis, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PD‐L1 Immunohistochemistry Comparability Study in Real‐Life Clinical Samples: Results of Blueprint Phase 2 Project

Hui Yu, Keith M. Kerr, Ignacio Wistuba, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study

F. Galateau-Sallé, W. Travis, A. Marchevsky, 2018, Modern Pathology.

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

A. Nicholson, A. Borczuk, L. Chirieac, 2018, Journal of Thoracic Oncology.

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Martin L. Miller, Darwin Q. Ye, P. Beltrão, 2021, bioRxiv.

Pathological findings in spontaneous pneumothorax specimens: does the incidence of unexpected clinically significant findings justify routine histological examination?

J. Sauter, K. Butnor, Kelly J Butnor, 2015, Histopathology.

Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi institutional study of the International Mesothelioma Panel from MESOPATH Reference Center.

G. Wainrib, P. Courtiol, C. Maussion, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma

M. Ladanyi, M. Zauderer, W. Travis, 2019, Modern Pathology.

Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach

David R. Jones, V. Seshan, M. Ladanyi, 2019, Clinical Cancer Research.

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC

Ash A. Alizadeh, Daniel K. Wells, C. Liu, 2020, Clinical Cancer Research.

Identification and localization of major soluble vitreous proteins in human ocular tissue.

T. Olsen, J. Sauter, Cidi Chen, 2004, American journal of ophthalmology.

Results from the 2019 American Society of Cytopathology survey on rapid onsite evaluation (ROSE)-part 2: subjective views among the cytopathology community.

Christopher C. Griffith, P. Illei, J. Reynolds, 2020, Journal of the American Society of Cytopathology.

Co-existence of Sarcina Organisms and Helicobacter pylori Gastritis/Duodenitis in Pediatric Siblings

R. Wilcox, J. Sauter, K. Butnor, 2013, Journal of clinical & anatomic pathology.

The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study

M. Ladanyi, M. Zauderer, M. Kris, 2021, The Lancet. Digital health.

Systemic and oligo-acquired resistance to PD-(L)1 blockade in lung cancer.

C. Rudin, V. Rusch, R. Perez-Johnston, 2022, Clinical Cancer Research.

Testing of Integrated Human Papillomavirus mRNA Decreases Colposcopy Referrals: Could a Change in Human Papillomavirus Detection Methodology Lead to More Cost-Effective Patient Care?

J. Sauter, S. Mount, G. Leiman, 2014, Acta Cytologica.

Type A thymoma presenting with bone metastasis

C. Antonescu, W. Travis, M. Bains, 2018, Histopathology.

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression.

S. Digumarthy, M. Hellmann, K. Kehl, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

SMARCA4-deficient Thoracic Sarcoma (SDTS): A Recently Recognized Entity with Distinct Cytomorphology that can be Diagnosed on Cytology Specimens

N. Rekhtman, J. Sauter, J. Montecalvo, 2018, Journal of the American Society of Cytopathology.

Response and durability of anti-PD-(L)1 therapy in never- or light-smokers with non-small cell lung cancer (NSCLC) and high PD-L1 expression.

M. Mino‐Kenudson, A. Shaw, M. Hellmann, 2018 .

MA 05.02 STK11/LKB1 Loss of Function Genomic Alterations Predict Primary Resistance to PD-1/PD-L1 Axis Blockade in KRAS-Mutant NSCLC

C. Rudin, P. Jänne, I. Wistuba, 2017 .

Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting

M. Zauderer, W. Travis, N. Rekhtman, 2023, Cancer cytopathology.

A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma

E. Yorke, M. Zauderer, V. Rusch, 2022, JTO clinical and research reports.

Acquired resistance to PD-1 blockade in NSCLC.

Martin L. Miller, M. Hellmann, D. Memon, 2020 .

Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade.

Daniel K. Wells, Ansuman T. Satpathy, C. Rudin, 2023, Cancer cell.

Brief Report: Multimodality Therapy in Patients with Primary Pericardial Mesothelioma.

E. Yorke, M. Zauderer, V. Rusch, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Diagnosis of thoracic SMARCA4‐deficient undifferentiated tumor in cytology

N. Rekhtman, E. Riedel, J. Sauter, 2023, Cancer cytopathology.

Long-term responders to PD-1 blockade in patients with advanced non-small cell lung cancer (NSCLC).

B. Taylor, M. Kris, M. Hellmann, 2020 .

Comparison of immunohistochemistry, next generation sequencing and fluorescence in situ hybridization for detection of MTAP loss in pleural mesothelioma.

M. Zauderer, N. Rekhtman, M. Offin, 2024, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma.

M. Zauderer, M. Ginsberg, A. Rimner, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.